ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Blocking the PI3K pathway enhances the efficacy of ALK-targeted therapy in EML4-ALK-positive nonsmall-cell lung cancer.

Lin Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.